<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02396888</url>
  </required_header>
  <id_info>
    <org_study_id>71-13</org_study_id>
    <nct_id>NCT02396888</nct_id>
  </id_info>
  <brief_title>Effects of Local Insulin on Wound Angiogenesis</brief_title>
  <official_title>Effects of Local Insulin on Angiogenesis in Acute Wounds in Non-diabetic Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Universidad Autonoma de San Luis Potosí</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized, split plot, double-blind, placebo controlled trial. Half of the wounds surface
      was applied daily with insulin and the other half with saline solution as placebo. Biopsy
      specimens of the two sides were obtained on days 0 and 14. Number of blood vessels will be
      evaluated as main outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized, split plot, double-blind, placebo controlled trial. Non-diabetic patients with
      full-thickness wounds will be treated in the following manner: in half of the surface insulin
      will be applied in a daily basis, on the other half, saline solution will be used as placebo.
      Biopsy specimens of both sides will be obtained on days 0 and 14. Number of blood vessels
      will be evaluated as main outcome.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of blood vessels</measure>
    <time_frame>14 days</time_frame>
    <description>In a biopsy taken at baseline, blood vessels will be counted</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoglycaemia</measure>
    <time_frame>14 days</time_frame>
    <description>Presence of capillary blood glucose of &lt;60 mg/dl</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Angiogenesis</condition>
  <arm_group>
    <arm_group_label>Insulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Half of the wound surface was treated daily with intermediate insulin. Allocation was randomized.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Half of the wound surface was treated daily with normal saline. Allocation was randomized.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin</intervention_name>
    <description>Half of the wound surface was treated daily with 10 units of intermediate insulin.</description>
    <arm_group_label>Insulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Half of the wound surface was treated daily with 0.1 cc of normal saline.</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nondiabetic patients with full-thickness acute wounds

        Exclusion Criteria:

          -  Diabetic patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jorge Aguilar-García, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Central Dr. Ignacio Morones Prieto</name>
      <address>
        <city>San Luis Potosí</city>
        <zip>78290</zip>
        <country>Mexico</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <results_reference>
    <citation>Martínez-Jiménez MA, Aguilar-García J, Valdés-Rodríguez R, Metlich-Medlich MA, Dietsch LJ, Gaitán-Gaona FI, Kolosovas-Machuca ES, González FJ, Sánchez-Aguilar JM. Local use of insulin in wounds of diabetic patients: higher temperature, fibrosis, and angiogenesis. Plast Reconstr Surg. 2013 Dec;132(6):1015e-9e. doi: 10.1097/PRS.0b013e3182a806f0.</citation>
    <PMID>24281606</PMID>
  </results_reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2015</study_first_submitted>
  <study_first_submitted_qc>March 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2015</study_first_posted>
  <last_update_submitted>March 18, 2015</last_update_submitted>
  <last_update_submitted_qc>March 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 24, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Central &quot;Dr. Ignacio Morones Prieto&quot;</investigator_affiliation>
    <investigator_full_name>MARIO AURELIO MARTÍNEZ-JIMÉNEZ</investigator_full_name>
    <investigator_title>General Surgeon</investigator_title>
  </responsible_party>
  <keyword>Blood vessel</keyword>
  <keyword>Fibroplasia</keyword>
  <keyword>Wound healing</keyword>
  <keyword>Insulin</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

